https://scholars.lib.ntu.edu.tw/handle/123456789/587684
標題: | Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience | 作者: | HUNG-HSUAN YEN CHIUNG-NIEN CHEN CHI-CHUAN YEH I-RUE LAI |
關鍵字: | Adjuvant chemotherapy; Gastric cancer; S-1; Tegafur; UFT | 公開日期: | 17-四月-2021 | 卷: | 19 | 期: | 1 | 來源出版物: | World journal of surgical oncology | 摘要: | Adjuvant tegafur-gimeracil-oteracil (S-1) is commonly used for gastric cancer in Asia, and tegafur-uracil (UFT) is another oral fluoropyrimidine when S-1 is unavailable. The real-world data of adjuvant UFT has less been investigated. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/587684 | ISSN: | 1477-7819 | DOI: | 10.1186/s12957-021-02233-2 | SDG/關鍵字: | gimeracil plus oteracil potassium plus tegafur; UFT; antineoplastic agent; antineoplastic antimetabolite; oteracil; S 1 (combination); tegafur; uracil; adult; Article; cancer adjuvant therapy; cancer chemotherapy; cancer staging; cohort analysis; comparative study; female; gastrectomy; health care system; health insurance; human; major clinical study; male; middle aged; monotherapy; overall survival; recurrence free survival; retrospective study; stomach cancer; Taiwan; treatment outcome; adjuvant chemotherapy; aged; disease free survival; drug combination; pathology; prognosis; stomach tumor; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Drug Combinations; Female; Humans; Middle Aged; Neoplasm Staging; Oxonic Acid; Prognosis; Stomach Neoplasms; Tegafur; Treatment Outcome; Uracil |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。